ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,368Medicare Part D Prescriptions Filled, Including Refills

Rank: 319 out of 6645

$1.16M Total Retail Price of All Prescriptions

Rank: 235 out of 6645

428 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 14,976 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ATELVIA 978 962 10 1 91
AMLODIPINE BESYLATE 539 528 2 2
MELOXICAM 519 496 3 46
SIMVASTATIN 511 502 4 1
ZOLPIDEM TARTRATE 483 482 5 17
LIDODERM 457 441 6 53
AZITHROMYCIN 424 409 7 44
DONEPEZIL HCL 423 411 8 27
ALENDRONATE SODIUM 395 386 9 14
OMEPRAZOLE 336 324 10 6
TAMSULOSIN HCL 304 304 11 22
NITROSTAT 277 271 12 193
DIOVAN 252 252 13 19
TRIAMCINOLONE ACETONIDE 250 232 14 55
ISOSORBIDE MONONITRATE ER 242 237 15 66
CELEBREX 231 229 16 54
PLAVIX 206 206 17 49
ATORVASTATIN CALCIUM 202 201 18 10
AMLODIPINE BESYLATE-BENAZEPRIL 200 198 19 97
LOSARTAN POTASSIUM 194 194 20 12
CLOPIDOGREL 188 188 21 36
NEXIUM 187 187 22 40
METFORMIN HCL 185 166 23 7
PATANOL 174 173 24 131
BENICAR 170 170 25 84
METOPROLOL SUCCINATE 168 168 26 24
CRESTOR 158 157 27 34
LOVAZA 146 146 28 68
LEVOTHYROXINE SODIUM 143 133 29 4
LIPITOR 141 141 30 69
GABAPENTIN 135 133 31 18
ACTOS 135 135 31 71
PATADAY 124 117 33 183
SINGULAIR 119 118 34 76
ADVAIR DISKUS 114 107 35 45
DIOVAN HCT 112 111 36 64
TERAZOSIN HCL 111 111 37 48
LOSARTAN-HYDROCHLOROTHIAZIDE 108 94 38 62
ZENPEP 103 91 39 210
JANUVIA 102 102 40 38
FINASTERIDE 101 101 41 73
GLIPIZIDE 97 97 42 23
TRICOR 95 83 43 138
IBUPROFEN 91 88 44 42
CLONIDINE HCL 84 84 45 56
CREON 83 83 46 114
PROAIR HFA 82 81 47 32
SOTALOL 80 80 48 332
ATENOLOL 79 79 49 8
PRAVASTATIN SODIUM 78 69 50 20
SINGLE USE SWAB 73 70 51 350
POTASSIUM CHLORIDE 72 66 52 28
ACARBOSE 71 71 53 211
KETOCONAZOLE 71 71 53 196
ACETAMINOPHEN-CODEINE 71 70 S3 53 80
AMOXICILLIN 68 68 56 107
VOLTAREN 65 65 57 108
PAROXETINE HCL 62 62 58 72
ACTONEL 59 59 59 92
ENABLEX 59 59 59 301
FLUTICASONE PROPIONATE 58 56 61 26
PROCTOSOL-HC 57 57 62 517
BENICAR HCT 57 56 62 158
AVODART 56 56 64 99
FUROSEMIDE 56 56 64 11
PANTOPRAZOLE SODIUM 55 47 66 29
LEVOFLOXACIN 54 52 67 83
FLUOCINONIDE 50 50 68 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.